HG-7-86-01 is a potent and selective type II tyrosine kinase inhibitor with antiproliferative activity against mutant T315I- Bcr-Abl for the treatment of chronic myeloid leukemia (CML).
Molecular Weight:
562.57
Purity:
99.07%
CAS Number:
[1258391-14-8]
Formula:
C28H21F3N6O2S
Target:
Bcr-Abl
T86575
T86575
* VAT and and shipping costs not included. Errors and price changes excepted